FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

409205009: Aprepitant (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2464656013 Aprepitant (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2471015014 Aprepitant en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3197001000005111 aprepitant da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aprepitant (substance) Is a Neurokinin 1 receptor antagonist true Inferred relationship Some
Aprepitant (substance) Is a Triazole derivative false Inferred relationship Some
Aprepitant (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Neurokinin 1 receptor antagonist (disposition) true Inferred relationship Some
Aprepitant (substance) Is a Substance with triazole structure (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely aprepitant 80 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aprepitant (substance) Inferred relationship Some
Aprepitant 125 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aprepitant (substance) Inferred relationship Some
aprepitant 80 mg + 125 mg kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aprepitant (substance) Inferred relationship Some
Product containing aprepitant (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aprepitant (substance) Inferred relationship Some 1
Product containing precisely aprepitant 80 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aprepitant (substance) Inferred relationship Some 1
Product containing precisely aprepitant 80 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aprepitant (substance) Inferred relationship Some 1
Aprepitant 125 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aprepitant (substance) Inferred relationship Some 1
Aprepitant 125 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aprepitant (substance) Inferred relationship Some 1
Product containing precisely aprepitant 80 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Aprepitant (substance) Inferred relationship Some 1
Aprepitant 125 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Aprepitant (substance) Inferred relationship Some 1
Aprepitant-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aprepitant (substance) Inferred relationship Some 1
Aprepitant only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aprepitant (substance) Inferred relationship Some 1
Aprepitant only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aprepitant (substance) Inferred relationship Some 1
Product containing precisely aprepitant 40 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aprepitant (substance) Inferred relationship Some 1
Product containing precisely aprepitant 40 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Aprepitant (substance) Inferred relationship Some 1
Product containing precisely aprepitant 125 milligram/1 sachet powder for conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Aprepitant (substance) Inferred relationship Some 1
Product containing precisely aprepitant 125 milligram/1 sachet powder for conventional release oral suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aprepitant (substance) Inferred relationship Some 1
Aprepitant 165 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Aprepitant (substance) Inferred relationship Some 1
Aprepitant 165 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aprepitant (substance) Inferred relationship Some 1

Reference Sets

GB English

Back to Start